AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comNOV 43 min read$CLVT

What Clarivate (CLVT) Said on Its Q3 Earnings Call

Clarivate (CLVT) reported Q3 earnings, highlighting 1% growth in recurring organic revenue and positive ACV growth. The company cited a U.S. Patent and Trademark Office selection and plans for an AI-native IP platform, IPOne. Margins expanded by 300 basis points, and the company updated its 2026 outlook, excluding divested businesses. CLVT expects $1.965B-$1.985B in revenue and $865M-$885M in adjusted EBITDA.

Original reporting
finance.yahoo.com
Published Nov 4, 2026, 5:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 5:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
What Clarivate (CLVT) Said on Its Q3 Earnings Call — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CLVTBearishMed
01

Why it matters

The updated guidance and AI initiatives provide a fresh catalyst for the stock, while disposals may affect near-term cash flow.

02

Market read

Clarivate's guidance lift and AI product rollout could drive short-term price appreciation, with sector peers watching for similar trends.

03

What to watch

Potential headwinds from the wind-down of low-margin IP products and higher tax expenses.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

Clarivate's Q3 earnings call highlighted modest organic revenue growth, AI product expansion, and a strategic divestiture of its Life Sciences & Healthcare unit.

Company-level read

Ticker impact

$CLVTBearishHigh confidence
Context

Clarivate released Q3 results and raised full-year revenue and EBITDA guidance, providing new forward-looking numbers.

Expected impact

likely upward pressure as investors price in higher revenue and margin expectations

Evidence & confidence

Guidance beats prior expectations and includes specific revenue, EBITDA, and EPS targets, which are material for valuation.

Market effects

Sector

Higher growth outlook for analytics and IP data services may lift peers in the information services sector.

Regional

U.S. listed data and analytics firms could see modest gains.

Global

Limited to the niche analytics market; no broad macro effect.

Counterpoint

What could challenge this read

If the guidance is overly optimistic, the stock could face disappointment on actual performance.

Key entities

  • Executive
    Shem Tov

    CEO of Clarivate, presented the earnings call.

  • Executive
    Michael Easton

    CFO, discussed financial metrics and debt reduction.

Read at source← All news

StoryClarivate posts Q3 loss, beats EPS, but revenue miss follows Life Sciences divestiture

Also covered by

5 outlets

Related articles

NOV 4
$CLVTHighAI 8/10

Clarivate Launches Cash Offers for Up to $500 Million of Notes

Clarivate (CLVT) initiated cash tender offers for up to $500 million in outstanding notes, including $400 million for 3.875% 2028 notes and $100 million for 4.875% 2029 notes. The 2029 notes offer $928.75 per $1,000 principal. Offers expire November 10, 2026, with settlement expected November 13, 2026, according to the company.

tradingview.com1 min
NOV 3
$CLVTMed

Clarivate Plc Q3 2026 Earnings Call Summary

Clarivate reported Q3 2026 earnings, highlighting 1.8% organic ACV growth and 300 basis points of adjusted EBITDA margin expansion. The company completed the Life Sciences & Healthcare divestiture, focusing on higher-quality, recurring revenue. Management expects Q4 2026 organic revenue growth to exceed 2% and targets 10-15% free cash flow growth in 2027. One-time transaction costs of $30 million were incurred, and free cash flow guidance was adjusted to $320M-$340M.

finance.yahoo.com7 min